Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chouaib

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Cancer Research|February 1, 1994
Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expressionA Zyad, J Bénard, T Tursz, et al.
International Journal of Cancer|December 2, 1992
The development of human tumor-cell resistance to TNF-alpha does not confer resistance to cytokine-induced cellular cytotoxic mechanismsA Zyad, D Branellec, Y Mahé, et al.
European Cytokine Network|July 10, 1999
Methyltransferase inhibitor S-adenosyl-L-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathwayV A Shatrov, M Ameyar, Z Cai, et al.
Blood|September 10, 1998
The induction of nitric oxide by interleukin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activityO Salvucci, J P Kolb, B Dugas, et al.
European Journal of Immunology|April 1, 1992
Tumor necrosis factor-mediated cell lysis in vitro: relationship to cAMP accumulation and guanine nucleotide-binding proteinsD Branellec, P De Cremoux, P Barreau, et al.
Journal of Clinical Laboratory Analysis|January 1, 1990
Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generationJ Y Blay, D Branellec, E Robinet, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1988
[Functional interaction between the tumor necrosis factor and interleukin 2 during induction of lymphokine activated killer cytotoxic activity]J Y Blay, J Bertoglio, F Gay, et al.
Frontiers in Oncology|October 27, 2023
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistanceR F Zaarour, M Ribeiro, B Azzarone, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988
Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2S Chouaib, J Bertoglio, J Y Blay, et al.
International Journal of Oncology|May 10, 2011
In-vivo effect of the combination of tnf and adriamycin against a human breast cell-line expressing the mdr-phenotypeA Zyad, Z Cai, J Morizet, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Cancer Research|February 1, 1994
Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expressionA Zyad, J Bénard, T Tursz, et al.
International Journal of Cancer|December 2, 1992
The development of human tumor-cell resistance to TNF-alpha does not confer resistance to cytokine-induced cellular cytotoxic mechanismsA Zyad, D Branellec, Y Mahé, et al.
European Cytokine Network|July 10, 1999
Methyltransferase inhibitor S-adenosyl-L-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathwayV A Shatrov, M Ameyar, Z Cai, et al.
Blood|September 10, 1998
The induction of nitric oxide by interleukin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activityO Salvucci, J P Kolb, B Dugas, et al.
European Journal of Immunology|April 1, 1992
Tumor necrosis factor-mediated cell lysis in vitro: relationship to cAMP accumulation and guanine nucleotide-binding proteinsD Branellec, P De Cremoux, P Barreau, et al.
Journal of Clinical Laboratory Analysis|January 1, 1990
Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generationJ Y Blay, D Branellec, E Robinet, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1988
[Functional interaction between the tumor necrosis factor and interleukin 2 during induction of lymphokine activated killer cytotoxic activity]J Y Blay, J Bertoglio, F Gay, et al.
Frontiers in Oncology|October 27, 2023
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistanceR F Zaarour, M Ribeiro, B Azzarone, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988
Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2S Chouaib, J Bertoglio, J Y Blay, et al.
International Journal of Oncology|May 10, 2011
In-vivo effect of the combination of tnf and adriamycin against a human breast cell-line expressing the mdr-phenotypeA Zyad, Z Cai, J Morizet, et al.
Pageof 13